CLINICAL_TRIALS
trial_result
· 2022-03-21
Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients [Phase 3]
Summary
Phase 3 trial evaluating favipiravir for moderate to severe COVID-19 was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Covid19 | Phase 3 | Status: TERMINATED | Results posted: 2022-03-21